Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BAXTER INTERNATIONAL INCBAX · Entity 1707 | SVP, President, APAC | March 02, 2022 | March 04, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BAXTER INTERNATIONAL INC
Report date March 02, 2022 · Filed March 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $1 par valueSEC Table I · non-derivative | Direct | 22,002 |
Reported balance
After 2022-03-02 transaction · row 1
1 source rowRow 1 · 2022-03-02 · Grant · Acquired 7,432 · Balance 22,002 F1: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $85.23 · Expires 2032-03-02 | Direct | 34,454 |
Reported balance
After 2022-03-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-02 · Grant · Acquired 34,454 · Balance 34,454 F2: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan.
F2: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2022 Filed Mar 4, 2022 21:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 34,454 | $0.00 Strike: $85.23 | $0.00 |
DisclosureSEC source: 0001062993-22-006846 · form4.xml · derivative · entry 2 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,454 Underlying: Common Stock, $1 par value · 34,454 shares Expires 2032-03-02 F2 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:08 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 7,432 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006846 · form4.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,002 F1 · shares: The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 2, 2023, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Baxter International Inc. 2021 Incentive Plan. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 4,056 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004277 · form4.xml · nonDerivative · entry 2 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,570 F2 · shares: Represents shares awarded from the 2019 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:15 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-004277 · form4.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,514 F1 · shares: Represents shares awarded from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2019 PSUs). The award provided that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2021 to December 31, 2021 performance period. These shares have vested as the relevant three-year performance period January 1, 2019 to December 31, 2021 (the Three-Year Performance Period) has ended. Read SEC document |
| April 12, 2021 Filed Apr 14, 2021 20:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 10,999 | $84.79 | $932,605.21 |
DisclosureSEC source: 0001712314-21-000004 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,041 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Frye with respect to certain vested restricted stock units previously granted by Baxter International Inc. ("BII") to Mr. Frye. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $84.38 through $85.02. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| March 03, 2021 Filed Mar 5, 2021 21:09 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 79,201 | $0.00 Strike: $77.15 | $0.00 |
DisclosureSEC source: 0001712314-21-000002 · edgar.xml · derivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,201 Underlying: Common Stock, $1 par value · 79,201 shares Expires 2031-03-03 F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 3, 2022, the first anniversary of the grant date. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:10 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 635 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-21-000001 · edgar.xml · nonDerivative · entry 3 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,989 F3 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2020 to December 31, 2020. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021). Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:10 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 2,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-21-000001 · edgar.xml · nonDerivative · entry 2 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,354 F2 · shares: Represents shares awarded from the 2018 PSUs. The award provides that fifty percent of the performance share units are earned based on Baxter's Total Shareholder Return (TSR) performance over the Three-Year Performance Period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's TSR during the Three-Year Performance Period. These shares have vested as the Three-Year Performance Period has ended. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 21:10 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 659 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-21-000001 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,935 F1 · shares: Represents shares awarded from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter International Inc. (Baxter) as of such date (the 2018 PSUs). The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Margin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares awarded based on Baxter's OM during the January 1, 2020 to December 31, 2020 performance period. These shares have vested as the relevant three-year performance period January 1, 2018 to December 31, 2020 (the Three-Year Performance Period) has ended. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 20:02 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 3,742 | $91.00 | $340,522.00 |
DisclosureSEC source: 0001712314-20-000003 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,216 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Frye with respect to certain vested restricted stock units previously granted by Baxter International Inc. to Mr. Frye. Read SEC document |
| March 20, 2020 Filed Mar 23, 2020 21:30 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 57,216 | $0.00 Strike: $75.75 | $0.00 |
DisclosureSEC source: 0001712314-20-000002 · edgar.xml · derivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,216 Underlying: Common Stock, $1 par value · 57,216 shares Expires 2030-03-20 F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on March 22, 2021, the first anniversary of the grant date. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 20:45 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-20-000001 · edgar.xml · nonDerivative · entry 2 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,917 F2 · shares: Represents shares earned from the performance share unit award granted on February 28, 2019 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2019 to December 31, 2019. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from Janaury 1, 2019 through December 31, 2021). Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 20:45 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-20-000001 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,131 F1 · shares: Represents shares earned from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's OM performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2019 through December 31, 2019. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2018 through December 31, 2020). Read SEC document |
| October 14, 2019 Filed Oct 16, 2019 20:12 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | SaleCommon Stock, $1 par value | 3,332 | $88.00 | $293,216.00 |
DisclosureSEC source: 0001712314-19-000003 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,391 F1 · kind: Transaction effected pursuant to a Rule 10b5-1 trading plan entered into by Mr. Frye with respect to certain vested restricted stock units previously granted by Baxter International Inc. ("BII") to Mr. Frye. F2 · price: Price reflects weighted average sales price. Range of prices for transactions are $88.00 through $88.01. Full information regarding the number of shares sold at each separate price will be provided by BII upon request. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 22:13 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 48,011 | $0.00 Strike: $74.73 | $0.00 |
DisclosureSEC source: 0001712314-19-000002 · edgar.xml · derivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,011 Underlying: Common Stock, $1 par value · 48,011 shares Expires 2029-02-28 F1 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on February 28, 2020, the first anniversary of the grant date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 21:09 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 1,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-19-000001 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,597 F1 · shares: Represents shares earned from the performance share unit award granted on March 1, 2018 pursuant to the Equity Plan adopted by Baxter as of such date. The award provides that fifty percent of the performance share units are earned based on Baxter's Adjusted Operating Martin (OM) performance, as assessed annually over a three-year period. One-third of the OM performance share units are allocated to each one-year period. The number of shares reported on this Form 4 represents the shares earned based on Baxter's OM, as assessed from January 1, 2018 through December 31, 2018. These shares are scheduled to vest after the end of the relevant three-year performance period (which runs from January 1, 2018 through December 31, 2020). Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 20:34 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | Tax withholdingCommon Stock, $1 par value | 370 | $74.79 | $27,672.30 |
DisclosureSEC source: 0001712314-18-000002 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,810 F1 · shares: Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of partial vesting of restricted stock granted on September 1, 2017. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:14 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantStock Option (Right to Buy) · Derivative | 44,812 | $0.00 Strike: $66.31 | $0.00 |
DisclosureSEC source: 0001712314-18-000001 · edgar.xml · derivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,812 Underlying: Common Stock, $1 par value · 44,812 shares Expires 2028-03-01 F1 · derivative.exercise_date: The option becomes exercisable in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $62.23 | $0.00 |
DisclosureSEC source: 0001712314-17-000002 · edgar.xml · derivative · entry 3 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock, $1 par value · 40,000 shares Expires 2027-09-01 F3 · derivative.exercise_date: The options become exercisable in three equal annual installments beginning on September 4, 2018, the first anniversary of the grant date. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 11,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-17-000002 · edgar.xml · nonDerivative · entry 2 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 F2 · shares: The restricted stock units will vest in three equal annual installments beginning on September 4, 2018, the first anniversary of the grant date. Read SEC document |
| September 01, 2017 Filed Sep 6, 2017 21:04 UTC | BAXTER INTERNATIONAL INC BAX · Entity 1707 | GrantCommon Stock, $1 par value | 7,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001712314-17-000002 · edgar.xml · nonDerivative · entry 1 Frye Andrew · CIK 0001712314 · SVP, President, APAC 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,000 F1 · shares: The restricted stock units will vest on September 1, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.